Home Industry Finance UAE-based BR Shetty’s fortune drops by $1.5bn since Muddy Waters attack The family’s troubles began last month when Block’s Muddy Waters Capital issued a report criticising NMC’s accounts by Bloomberg January 26, 2020 The year is starting off much like the last one ended for the Shetty family. The billionaire clan behind financial services firm Finablr Plc and hospital operator NMC Health has seen its fortune drop more than $1.5bn since it came under fire in December from short seller Carson Block. The latest blow came Friday after a filing revealed the Shettys pledged more than half their stake in Finablr to secure loans. The payment processor’s shares tumbled as much as 34 per cent in London. A spokesman for the family had no immediate comment when reached by email. The family’s troubles began last month when Block’s Muddy Waters Capital issued a report criticising NMC’s accounts and disclosing a short position, sending shares down. Since then, a cyberattack rocked one of Finablr’s popular brands — Travelex Holdings — and NMC plunged again after investors sold shares worth almost $500m. The healthcare firm has named former FBI director Louis Freeh to examine Block’s claims. Bavaguthu Raghuram Shetty, 77, founded NMC in 1975 after moving to Abu Dhabi from his native India. It’s now the United Arab Emirates’ biggest private health-care provider. He created Finablr in 2018 to consolidate his finance brands and listed the company on the London Stock Exchange last year. The family’s stakes in both firms were worth almost $3bn before Muddy Waters published its report, but they have been cut in half since, according to the Bloomberg Billionaires Index. Tags Abu Dhabi Bavaguthu Raghuram Shetty Finablr Healthcare Muddy Waters Capital Shetty family Travelex Holdings 0 Comments You might also like Abu Dhabi Crown Prince inaugurates CMA Terminals Khalifa Port US private credit firm Golub Capital to set up base in Abu Dhabi ‘Make Bitcoin Great Again’: Eric Trump attends Abu Dhabi crypto gathering Informa’s Adam Andersen on how CPHI ME is building bridges in the pharma sector